Showing results (21-30 of 516) with videos related to
Sort By:
Pageof 52
ERJ Open Research|April 15, 2025
Two for the price of one: GLP-1 analogues, a new approach in treating severe COPD patients with diabetesAugusta Beech, Ernesto CrisafulliPlos One|February 10, 2021
Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarkerBert Rutten, Simon Young, Magdalena Rhedin, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|July 8, 2026
COPD maintenance trials use heterogeneous outcomes and measurement instruments: a systematic literature reviewVi Truong, Sulaiman Bin Safar, Sachin Ananth, et al.Handbook of Experimental Pharmacology|November 14, 2016
Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial DesignDave SinghBritish Journal of Clinical Pharmacology|November 8, 2014
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesDave SinghRespirology (Carlton, Vic.)|April 8, 2021
Pharmacological treatment of stable chronic obstructive pulmonary diseaseDave SinghTuberculosis and Respiratory Diseases|June 25, 2020
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid EffectsDave SinghTuberculosis and Respiratory Diseases|September 15, 2017
Small Airway Disease in Patients with Chronic Obstructive Pulmonary DiseaseDave SinghExpert Opinion on Pharmacotherapy|July 10, 2018
Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary diseaseDave SinghExpert Review of Respiratory Medicine|May 19, 2010
Salmeterol/fluticasone propionate combination in the treatment of COPDS Dave SinghPageof 52